# Editas Medicine, Inc.: Form 8-K, filed May 5, 2026

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2026-05-05
- Accepted by EDGAR: May 5, 2026, 07:03 ET
- Period: 2026-05-05
- Accession: 0001650664-26-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000043/edit-20260505.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000043/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000165066426000043/edit-20260505.htm

Filed May 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001650664-26-000043. Last ingested by Listed: Nov 14, 2026, 21:28 ET. No prices; not investment advice.
